quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:19:00·9d
PRRelease
Life Time Group Holdings Inc. logo

Life Time to Report First Quarter 2026 Financial Results on May 5, 2026

LTH· Life Time Group Holdings Inc.
Consumer Discretionary
Original source

Companies

  • LTH
    Life Time Group Holdings Inc.
    Consumer Discretionary

Recent analyst ratings

  • Mar 12UpdateKeyBanc Capital Markets$40.00
  • Mar 11UpdateWells Fargo$37.00
  • Mar 10UpdateJefferies$40.00
  • Oct 27UpdateMorgan Stanley$39.00
  • Oct 17UpdateUBS$43.00
  • May 23UpdateCraig Hallum$45.00

Related

  • PR2d
    Life Time Launches HYBRID XT to Fuel Rise of Hybrid Fitness Competitions, Anchored by LT Games
  • PR7d
    Life Time Reinforces Leadership in VO₂ Max and Metabolic Testing with National Rollout of New Technology to its Athletic Country Clubs
  • PR14d
    Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX
  • PR15d
    Life Time Debuts First Luxury Athletic Country Club in Idaho, Bringing a 135,000-Square-Foot Wellness Destination to the Boise Area
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Life Time Group Holdings Inc.
  • PR30d
    The 60-Day Transformation Model That Works: Life Time's 60XT Challenge Returns March 30
  • INSIDER41d
    EVP &PRESIDENT CLUB OPERATIONS Javaheri Parham covered exercise/tax liability with 5,701 shares and sold $292,648 worth of shares (11,060 units at $26.46), decreasing direct ownership by 5% to 315,175 units (SEC Form 4)
  • ANALYST42d
    KeyBanc Capital Markets initiated coverage on Life Time with a new price target
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022